NKTX
Price:
$2.2026
Market Cap:
$157.59M
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, Ca...[Read more]
Industry
Biotechnology
IPO Date
2020-07-10
Stock Exchange
NASDAQ
Ticker
NKTX
According to Nkarta, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 205.23M. This represents a change of 17.99% compared to the average of 173.94M of the last 4 quarters.
The mean historical Enterprise Value of Nkarta, Inc. over the last ten years is 779.40M. The current 205.23M Enterprise Value has changed 2.53% with respect to the historical average. Over the past ten years (40 quarters), NKTX's Enterprise Value was at its highest in in the December 2020 quarter at 1.92B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.
Average
779.40M
Median
398.89M
Minimum
173.67M
Maximum
2.41B
Discovering the peaks and valleys of Nkarta, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 347.68%
Maximum Annual Enterprise Value = 2.41B
Minimum Annual Increase = -82.72%
Minimum Annual Enterprise Value = 173.67M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 173.67M | -21.55% |
| 2024 | 221.38M | -41.86% |
| 2023 | 380.79M | 24.12% |
| 2022 | 306.79M | -32.72% |
| 2021 | 456.00M | -75.57% |
| 2020 | 1.87B | 347.68% |
| 2019 | 416.99M | -82.72% |
The current Enterprise Value of Nkarta, Inc. (NKTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
258.62M
5-year avg
307.73M
10-year avg
779.40M
Nkarta, Inc.’s Enterprise Value is greater than Alector, Inc. (124.12M), greater than PepGen Inc. (111.71M), less than Fate Therapeutics, Inc. (342.02M), greater than Molecular Partners AG (62.13M), greater than Cassava Sciences, Inc. (-36687052.00), greater than Applied Therapeutics, Inc. (5.42M), greater than Cybin Inc. (90.03M), greater than Elicio Therapeutics, Inc. (60.98M), less than Vor Biopharma Inc. (1.04B), less than Forte Biosciences, Inc. (1.51B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 124.12M | $166.54M | |
| 111.71M | $137.30M | |
| 342.02M | $304.80M | |
| 62.13M | $150.42M | |
| -36687052.00 | $63.77M | |
| 5.42M | $14.86M | |
| 90.03M | $413.02M | |
| 60.98M | $61.59M | |
| 1.04B | $1.21B | |
| 1.51B | $1.57B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nkarta, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nkarta, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Nkarta, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Nkarta, Inc. (NKTX)?
What is the 3-year average Enterprise Value for Nkarta, Inc. (NKTX)?
What is the 5-year average Enterprise Value for Nkarta, Inc. (NKTX)?
How does the current Enterprise Value for Nkarta, Inc. (NKTX) compare to its historical average?